<DOC>
	<DOCNO>NCT01736358</DOCNO>
	<brief_summary>Despite overall reduction perioperative complication rate , post operative pain management ureteroscopic removal stone ( URS ) remain major factor delay discharge patient . The investigator hypothesize perioperative usage intranasal ketorolac provide reduction post operative opioid requirement , good post operative pain control , high anesthesia satisfaction faster recovery .</brief_summary>
	<brief_title>The Use Intranasal Ketoralac Pain Management</brief_title>
	<detailed_description>The prevalence incidence urolithiasis , kidney stone disease , increase general population . Life-time incidence urolithiasis estimate 5 % - 12 % . The treatment kidney stone depend stone type size , symptom severity , presence obstruction . URS common ambulatory procedure improve technological advance increase clinical utilization help decrease postoperative complication . Despite overall reduction perioperative complication rate , post operative pain management URS remain major factor delay discharge patient . Post operative pain URS usually treat opioids non steroidal anti inflammatory drug . Intranasal ketorolac ( SprixTM ) FDA approve pain formulation short term management ( 5 day ) moderate moderately severe pain require analgesia opioid level . The efficacy intranasal ketorolac formulation demonstrate placebo-controlled study patient follow major surgery . The primary objective study evaluate role perioperative usage single-dose intranasal ketorolac immediate post operative opioid requirement . Secondary objective study ( ) evaluate post operative pain score 30 minute surgery , 1 hour surgery , 2 hour surgery , ( b ) find incidence immediate ( discharge ) 24hrs post operative side effect target population , ( c ) find level anesthesia satisfaction target population , ( ) find time discharge target population , ( e ) compare two group post anesthesia discharge score .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Urolithiasis</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Ureteroscopic stone removal surgery stenting Age â‰¥ 18 year &lt; 65 year Stable patient stable vital sign Mentally competent able understand consent form Unstable patient Patients multiple trauma sit Patients allergy ketorolac component nasal spray preparation Patients active peptic ulcer disease History asthma , urticaria , allergictype reaction take aspirin NSAIDs Renal disease risk renal failure due volume depletion Pregnant nursing mother Nasal abnormality illness could affect absorption intranasal medication ( : nasal discharge , rhinitis , acute upper respiratory infection , acute epistaxis , nasal polyp , nasal tumor ) Any contraindication use Sprix , use Sprix would consistent approved package insert</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Sprix</keyword>
	<keyword>Intranasal ketoralac</keyword>
	<keyword>Ketoralac</keyword>
	<keyword>Urolithiasis</keyword>
	<keyword>Kidney stone</keyword>
	<keyword>Uretal stone</keyword>
	<keyword>Ureteroscopic removal stone</keyword>
	<keyword>URS</keyword>
	<keyword>Pain management</keyword>
	<keyword>Pain</keyword>
</DOC>